Informations générales (source: ClinicalTrials.gov)
Study of the Use of Non-invasive Ventilation in Bronchial Dilatation Disease (BRONCHINIV) (BRONCHINIV)
Observational
Centre Hospitalier Intercommunal Creteil (Voir sur ClinicalTrials)
janvier 2025
décembre 2025
24 mai 2025
This is a medical record data collection study. The goal of this non-interventional and
retrospective study is to describe the characteristics of the population currently being
monitored for bronchial dilatation who have been treated with long-term NIV. This is a
study based on data from medical records.
The assessment criteria will be :
- Epidemiological characteristics of the population with bronchial dilatation on
long-term NIV
- Reasons for initiation of NIV
- NIV adjustment methods
Etablissements
Les établissements d'Île-de-France dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données | |||||
---|---|---|---|---|---|
AP-HP - Hôpital Henri Mondor-Albert Chenevier | Frédéric SCHLEMMER, Lecturer hospital practitioner | Contact (sur clinicalTrials) | |||
CHI DE CRETEIL | Suela DEMIRI, Doctor, Hospital Practitioner | Contact (sur clinicalTrials) | |||
Les établissements sans correspondance certaine dans le répertoire FINESS dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données | |||||
Centre Hospitalier Universitaire de Dijon - 21000 - Dijon - France | Marjolaine GEORGES, Doctor, Hospital Practitioner | Contact (sur clinicalTrials) | |||
Centre Hospitalier Universitaire de Rennes - 35000 - Rennes - France | Maria Alejandra GALARZA JIMENEZ, Doctor, Hospital Practitioner | Contact (sur clinicalTrials) | |||
Centre Hospitalier Universitaire Toulouse - 31059 - Toulouse - France | Marion DUPUIS, Doctor, Hospital Practitioner | Contact (sur clinicalTrials) |
Critères
Tous
Inclusion Criteria:
- Patients over 18 years
- Predominant diagnosis of bronchiectatic disease, excluding cystic fibrosis,
confirmed by computed tomography
- Introduction of long-term NIV at a given point in the patient's care
- Patients over 18 years
- Predominant diagnosis of bronchiectatic disease, excluding cystic fibrosis,
confirmed by computed tomography
- Introduction of long-term NIV at a given point in the patient's care
- Patient's opposition to participating in this study
- Cystic fibrosis
- Predominant diagnosis of COPD or asthma, traction bronchiectasis, bronchiectasis
resulting from focal endobronchial lesion, sarcoidosis or active allergic
bronchopulmonary aspergillosis.